BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors

Summary

This phase I trial is studying the side effects and best dose of BMS-247550 when given together with carboplatin in treating patients with recurrent or refractory solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells

Timeline

Start

2001-10

Primary completion

2007-02

Completion

—

Drugs

Indications